• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Tarsus Pharmaceuticals Inc (NQ: TARS )

49.42 +2.63 (+5.62%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Tarsus Pharmaceuticals Inc

< Previous 1 2 3 4 Next >
Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
November 06, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Appoints Elizabeth Yeu, M.D., as Chief Medical Officer
November 05, 2024
Dr. Yeu transitions from her role as Chief Medical Advisor and Board Member to lead the Company’s newly created Medical Organization 
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
October 28, 2024
Via Benzinga
Analyst Ratings For Tarsus Pharmaceuticals
May 09, 2024
Via Benzinga
Tarsus Pharmaceuticals Inc. (NASDAQ: TARS) is a Stock Spotlight on 4/15
April 15, 2024
Via Investor Brand Network
A Glimpse Into The Expert Outlook On Tarsus Pharmaceuticals Through 4 Analysts
February 29, 2024
Via Benzinga
Tarsus Launches “Your Mitey Problem,” the First Direct-to-Consumer TV Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25%
October 17, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus to Participate in Fireside Chat at UBS Virtual Ophthalmology Day 2024
September 25, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus to Participate in Fireside Chat at the 2024 Wells Fargo Securities Healthcare Conference
August 28, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
TARS Stock Earnings: Tarsus Pharmaceuticals Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
TARS stock results show that Tarsus Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. 
Via InvestorPlace
Tarsus Reports Second Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
August 08, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
July 29, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus to Participate in Upcoming Investor Conferences
May 29, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Why Saia Shares Are Trading Lower? Here Are Other Stocks Moving In Friday's Mid-Day Session
July 26, 2024
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
May 13, 2024
Via Benzinga
Simple Ways To Stay With Trends: The Week In Charts
May 12, 2024
Has the market made its all-time highs? In this video I cover the stock and crypto markets. 
Via Talk Markets
Tarsus to Participate in Fireside Chat at the 2024 Bank of America Healthcare Conference
May 09, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Top 5 Health Care Stocks That Could Sink Your Portfolio In Q2
May 09, 2024
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
May 09, 2024
Via Benzinga
TARS Stock Earnings: Tarsus Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024
May 08, 2024
TARS stock results show that Tarsus Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Tarsus Reports First Quarter 2024 Financial Results and Recent Business Achievements
May 08, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
May 01, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
April 23, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus to Participate at Upcoming Investor Conferences
March 05, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
March 05, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Announces Pricing of $100.0 Million Public Offering
March 01, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
Tarsus Announces Proposed $100.0 Million Public Offering
February 29, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
ICU Medical To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Wednesday
February 28, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Tarsus Reports Strong Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Achievements
February 27, 2024
From Tarsus Pharmaceuticals, Inc
Via GlobeNewswire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap